{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:17:07Z","timestamp":1793812627837,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jacc.2018.04.067","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T18:08:22Z","timestamp":1531159702000},"page":"300-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Jennifer","family":"Sjaarda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.04.067_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.04.067_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib4","first-page":"1","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality","author":"Evans","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2009.812","article-title":"Mendelian randomization: nature\u2019s randomized trial in the post-genome era","volume":"301","author":"Thanassoulis","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.04.067_bib6","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2018.04.067_bib8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.04.067_bib9","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ahj.2007.09.009","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)","volume":"155","author":"Gerstein","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.04.067_bib10","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/CIRCULATIONAHA.115.015744","article-title":"Identifying novel biomarkers for cardiovascular events or death in people with dysglycemia","volume":"132","author":"Gerstein","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.04.067_bib11","first-page":"1121","article-title":"A\u00a0comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrg2796","article-title":"Genotype imputation for genome-wide association studies","volume":"11","author":"Marchini","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib14","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A\u00a0review of instrumental variable estimators for Mendelian randomization","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jacc.2018.04.067_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.04.067_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2018.04.067_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/bio.2015.0032","article-title":"A\u00a0novel approach to high-quality postmortem tissue procurement: the GTEx Project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.jacc.2018.04.067_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/blood.V71.2.430.430","article-title":"Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor","volume":"71","author":"Fibbe","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.04.067_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI113316","article-title":"Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation","volume":"81","author":"Kaushansky","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2018.04.067_bib22","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.138.6.1772","article-title":"Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity","volume":"138","author":"Segal","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2018.04.067_bib23","first-page":"701","article-title":"Interleukin-1 beta stimulates colony-stimulating factor-1 production in human term placenta","volume":"76","author":"Kauma","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2018.04.067_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.04.067_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1471-4906(02)02260-3","article-title":"GM-CSF in inflammation and autoimmunity","volume":"23","author":"Hamilton","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jacc.2018.04.067_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/344254a0","article-title":"Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins","volume":"344","author":"Rajavashisth","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2018.04.067_bib27","first-page":"291","article-title":"Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans","volume":"140","author":"Rosenfeld","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2018.04.067_bib28","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI119891","article-title":"Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice","volume":"101","author":"Rajavashisth","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2018.04.067_bib29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1194\/jlr.M005215","article-title":"Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis","volume":"51","author":"Shaposhnik","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2018.04.067_bib30","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1161\/STROKEAHA.115.010829","article-title":"Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip","volume":"46","author":"Lind","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2018.04.067_bib31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/ATVBAHA.107.161174","article-title":"Chemokines in atherosclerosis an update","volume":"28","author":"Zernecke","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.04.067_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.RES.86.2.131","article-title":"The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques","volume":"86","author":"Abi-Younes","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2018.04.067_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.RES.0000162100.52009.38","article-title":"SDF-1\u03b1\/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells","volume":"96","author":"Zernecke","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2018.04.067_bib34","first-page":"1","article-title":"The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease","volume":"5","author":"D\u00f6ring","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2018.04.067_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2014.10.094","article-title":"Plasma stromal cell-derived factor 1alpha\/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease","volume":"238","author":"Ghasemzadeh","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.04.067_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/eurheartj\/ehr091","article-title":"The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels","volume":"32","author":"Mehta","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.04.067_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00439-016-1647-9","article-title":"Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk","volume":"135","author":"Tragante","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2018.04.067_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1162\/REST_a_00011","article-title":"Two-sample instrumental variables estimators","volume":"92","author":"Inoue","year":"2010","journal-title":"Rev Econ Stat"},{"key":"10.1016\/j.jacc.2018.04.067_bib40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2017.09.022","article-title":"CANTOS ushers in a new calculus of inflammasome targeting for vascular protection\u2014and maybe more","volume":"26","author":"Verma","year":"2017","journal-title":"Cell Metab"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718348320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718348320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T16:29:32Z","timestamp":1693758572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718348320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0735109718348320"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.04.067","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.04.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}